Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VIEPAX XR TABLET 150MG - HSA Drug Approval Details

Approvals/HSA/VIEPAX XR TABLET 150MG

Approved

THERAPEUTIC

VIEPAX XR TABLET 150MG

DEXCEL PHARMA TECHNOLOGIES LTD.🇸🇬 Health Sciences Authority

Approval Date: Jun 29, 2020
Approval ID: 9b288e194a47740b
Company: DEXCEL PHARMA TECHNOLOGIES LTD.
Type: Therapeutic

Approval Details

Approval Id: 9b288e194a47740b
Drug Name: VIEPAX XR TABLET 150MG
Product Name: VIEPAX XR TABLET 150MG
Approval Number: SIN15968P
Approval Date: 2020-06-29
Registrant: APEX PHARMA MARKETING PTE. LTD.
Licence Holder: APEX PHARMA MARKETING PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, EXTENDED RELEASE
Route Of Administration: ORAL
Atc Code: N06AX16
Atc Item Name: venlafaxine
Pharma Manufacturer Name: APEX PHARMA MARKETING PTE. LTD.
Company Detail Path: /organization/f3877d86bd1d513a/apex-pharma-marketing-pte-ltd

Active Ingredients

Venlafaxine Hydrochloride eqv to Venlafaxine

150mg

VENLAFAXINE HYDROCHLORIDE EQV TO VENLAFAXINE

150 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 29, 2020

Approval ID

9b288e194a47740b

Type

Therapeutic

Back to HSA Approvals